Erasmus syndrom: About an observation;Syndrome d'Erasmus : à propos d'une observation

Revue de Pneumologie Clinique

Volumn 65, Issue 1, 2009, Pages 16-22

  Ajlani, H ^a   Meddeb, N ^a   Sahli, H ^a   Sellami, S ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Professional exposure; Pulmonary fibrosis; Scleroderma; Silica

Indexed keywords

COLCHICINE; NIFEDIPINE; PENICILLAMINE; PREDNISONE; SILICON DIOXIDE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL OBSERVATION; DYSPHAGIA; ERASMUS SYNDROME; HUMAN; LUNG FIBROSIS; MINER; OCCUPATIONAL EXPOSURE; RAYNAUD PHENOMENON; SCLERODERMA; SILICOSIS; SYNDROME; SYSTEMIC SCLEROSIS; MALE; MIDDLE AGED; MINING;

HUMANS; MALE; MIDDLE AGED; MINING; OCCUPATIONAL EXPOSURE; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SILICOSIS; SYNDROME;

EID: 66149147959     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneumo.2008.09.014     Document Type: Article

References (11)

1. Rodnan G.P., Benedek T.G., Medsger T.A., and Cammarata R.J. The association of progressive systemic sclerosis (sclerodermia) with coal miners pneumoconiosis and other forms of silicosis. Ann Intern Med 66 (1967) 323-334
2. Freneaux B., Freneaux J., Buyse N., and Le Van Quyen H. L'association silicose-sclérodermie. Nouv Presse Med 4 (1975) 2087-2090
3. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 59 (2002) 545-549
4. Kettaneh A., Al Moufti O., Tiev K.P., Chayet C., Tolédano C., Fabre B., et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a meta-analysis of case-control studies. J Rheumatol 34 (2007) 97-103
5. Cointrel C., Tillie-Leblond I., Lamblin C., Furon D., Tonnel A., and Wallaert B. Syndrome d'Erasmus : caractéristiques cliniques, tomodensitométriques, fonctionnelles respiratoires et biologiques du lavage bronchoalvéolaire. Rev Mal Resp 14 (1997) 21-26
6. Koeger A.C., Marre J.P., Rozenberg S., Gutmann L., and Bourgeois P. Maladies auto-immunes après exposition inhabituelle à la silice ou aux silicones. Trois observations. Ann Intern Med 143 (1992) 165-170
7. Clements P.J., Frust D.E., Wong W.K., Mayes M., White B., Wigley F., et al. High dose versus low dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 42 (1999) 1194-1203
8. Akesson A., Scheja A., Lundin A., and Wollheim F.A. Improvement pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum 37 (1994) 729-735
9. Airo P., Daniel E., Parrinello G., Antonioli C.M., Cavazzana I., Toniati P., et al. Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature pooled analysis of lung function test results. Clin Exp Rheumatol 22 (2004) 573-578
10. Dheda K., Lalloo U.G., Cassim B., and Mody M. Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. Clin Rheum 23 (2004) 306-309
11. Stratton R.J., Wilson H., and Black C.M. Pilot study of antithymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology 40 (2001) 84-88